‘To seek a true cure’: UNC researchers pioneer HIV research w...
In honor of World AIDS Day on Dec. 1, we take a look at the trailblazing ‘kick and kill’ method of attacking HIV to cure patients. UNC researchers have been working with GlaxoSmithKline on parallel studies at the UNC Cure Center for 18 months to advance this new method of combating the global epidemic of HIV.
UNC scientists named to European Union-funded global Zika research ...
The UNC School of Medicine was one of two U.S. institutions named to an international research consortium funded through the European Union’s Horizon 2020 Programme, which invested $49 million in Zika research and vaccine development at more than 20 laboratories in Europe and Brazil.
From Liberia to Chapel Hill: Compassionate Care and a Taste of Home
When David Wohl, MD, met Patience Wesseh in Liberia, her face was badly scarred by a burn injury, and he knew he could help. Since April when she arrived in Chapel Hill to begin her treatment at the North Carolina Jaycee Burn Center, Patience has brought her own unique flavor to Wohl’s home.
Two UNC doctors participating in Ebola clinical trial
William A. Fischer II and David Wohl are taking part in a clinical trial at ELWA Hospital in Monrovia, Liberia, in which plasma from survivors of Ebola virus disease is given to patients who are battling the disease.
Dispatch from Guinea: Containing Ebola
UNC’s Dr. William Fischer II has been working in an isolation area in Gueckedou, Guinea, since May 28, 2014, as part of a team from Doctors without Borders (Médecins Sans Frontières/MSF) to try to help reduce mortality from Ebola Virus in rural communities. Dr. Fischer was recruited by the World Health Organization (WHO) because of his critical care medicine expertise. With Dr. Fischer’s permission, we are posting his descriptive emails, that give insight into the experience of a frontline effort to contain the deadly pathogen.
Corbett continues quest for dengue fever vaccine
In this new series, we profile graduate students who conduct research in labs across the UNC School of Medicine. First up is Kizzmekia Corbett, who received an off-campus dissertation fellowship from the UNC Graduate School to travel to Sri Lanka. Corbett will collect blood samples to search for a specific antibody response to the dengue virus, a key step in creating a vaccine for the world's most widespread mosquito-borne disease.